Cardiotoxicity Associated with Gemcitabine: Literature Review and a Pharmacovigilance Study
Background: Gemcitabine is a nucleoside analog, widely used either alone or in combination, for the treatment of multiple cancers. However, gemcitabine may also be associated with cardiovascular adverse-drug-reactions (CV-ADR). Methods: First, we searched for all cases of cardiotoxicity associated w...
Main Authors: | Marc Hilmi, Stéphane Ederhy, Xavier Waintraub, Christian Funck-Brentano, Ariel Cohen, Aurore Vozy, Bénédicte Lebrun-Vignes, Javid Moslehi, Lee S. Nguyen, Joe-Elie Salem |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/13/10/325 |
Similar Items
-
Gemcitabine-Induced Cardiotoxicity in Patients Receiving Adjuvant Chemotherapy for Pancreatic Cancer: A Case Series
by: Salma Alam, et al.
Published: (2018-04-01) -
Sipuleucel‐T associated inflammatory cardiomyopathy: a case report and observations from a large pharmacovigilance database
by: Melissa Y.Y. Moey, et al.
Published: (2021-08-01) -
Neoplasia-Associated Pericarditis—Predictor of Cancer Progression?
by: Anca Boldan, et al.
Published: (2021-01-01) -
Graft Versus Host Disease Associated with Immune Checkpoint Inhibitors: A Pharmacovigilance Study and Systematic Literature Review
by: Lee S. Nguyen, et al.
Published: (2021-02-01) -
Toxicoderma by gemcitabine: About a case
by: Flora López-López, et al.
Published: (2018-02-01)